• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SCHEDULE 13G filed by OrthoPediatrics Corp.

    11/4/25 4:22:52 PM ET
    $KIDS
    Medical/Dental Instruments
    Health Care
    Get the next $KIDS alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    OrthoPediatrics Corp.

    (Name of Issuer)


    Common Stock, par value $0.00025 per share

    (Title of Class of Securities)


    68752L100

    (CUSIP Number)


    10/29/2025

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox not checked   Rule 13d-1(b)
    Checkbox checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    68752L100


    1Names of Reporting Persons

    Integrated Core Strategies (US) LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    1,382,496.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    1,382,496.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    1,382,496.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.5 %
    12Type of Reporting Person (See Instructions)

    OO


    SCHEDULE 13G

    CUSIP No.
    68752L100


    1Names of Reporting Persons

    Millennium Management LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    1,390,656.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    1,390,656.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    1,390,656.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.5 %
    12Type of Reporting Person (See Instructions)

    OO


    SCHEDULE 13G

    CUSIP No.
    68752L100


    1Names of Reporting Persons

    Millennium Group Management LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    1,390,656.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    1,390,656.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    1,390,656.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.5 %
    12Type of Reporting Person (See Instructions)

    OO


    SCHEDULE 13G

    CUSIP No.
    68752L100


    1Names of Reporting Persons

    Israel A. Englander
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    UNITED STATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    1,390,656.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    1,390,656.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    1,390,656.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.5 %
    12Type of Reporting Person (See Instructions)

    IN


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    OrthoPediatrics Corp.
    (b)Address of issuer's principal executive offices:

    2850 Frontier Drive, Warsaw, Indiana 46582
    Item 2. 
    (a)Name of person filing:

    Integrated Core Strategies (US) LLC Millennium Management LLC Millennium Group Management LLC Israel A. Englander
    (b)Address or principal business office or, if none, residence:

    Integrated Core Strategies (US) LLC c/o Millennium Management LLC 399 Park Avenue New York, New York 10022 Millennium Management LLC 399 Park Avenue New York, New York 10022 Millennium Group Management LLC 399 Park Avenue New York, New York 10022 Israel A. Englander c/o Millennium Management LLC 399 Park Avenue New York, New York 10022
    (c)Citizenship:

    Integrated Core Strategies (US) LLC - Delaware Millennium Management LLC - Delaware Millennium Group Management LLC - Delaware Israel A. Englander - United States
    (d)Title of class of securities:

    Common Stock, par value $0.00025 per share
    (e)CUSIP No.:

    68752L100
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox not checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox not checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    See response to Item 9 on each cover page.
    (b)Percent of class:

    See response to Item 11 on each cover page.
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    See response to Item 5 on each cover page.

     (ii) Shared power to vote or to direct the vote:

    See response to Item 6 on each cover page.

     (iii) Sole power to dispose or to direct the disposition of:

    See response to Item 7 on each cover page.

     (iv) Shared power to dispose or to direct the disposition of:

    See response to Item 8 on each cover page. The securities disclosed herein as potentially beneficially owned by Millennium Management LLC, Millennium Group Management LLC and Mr. Englander are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers that may be controlled by Millennium Group Management LLC (the managing member of Millennium Management LLC) and Mr. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). The foregoing should not be construed in and of itself as an admission by Millennium Management LLC, Millennium Group Management LLC or Mr. Englander as to beneficial ownership of the securities held by such entities.

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    Not Applicable
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    Not Applicable
    Item 8.Identification and Classification of Members of the Group.
     
    If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(K), so indicate under Item 3(k) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group.


    See Exhibit I
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    Integrated Core Strategies (US) LLC
     
    Signature:/s/ Gil Raviv
    Name/Title:Gil Raviv, Global General Counsel
    Date:11/03/2025
     
    Millennium Management LLC
     
    Signature:/s/ Gil Raviv
    Name/Title:Gil Raviv, Global General Counsel
    Date:11/03/2025
     
    Millennium Group Management LLC
     
    Signature:/s/ Gil Raviv
    Name/Title:Gil Raviv, Global General Counsel
    Date:11/03/2025
     
    Israel A. Englander
     
    Signature:/s/ Israel A. Englander
    Name/Title:Israel A. Englander
    Date:11/03/2025

    Comments accompanying signature:  ** INTEGRATED CORE STRATEGIES (US) LLC By: Integrated Holding Group LP, its Managing Member By: Millennium Management LLC, its General Partner
    Exhibit Information

    Exhibit I: Joint Filing Agreement, dated as of November 3, 2025, by and among Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.

    Get the next $KIDS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $KIDS

    DatePrice TargetRatingAnalyst
    12/10/2025$24.00Buy
    Canaccord Genuity
    4/7/2025$37.00Buy
    Lake Street
    1/25/2024$39.00 → $31.00Buy → Hold
    Truist
    3/3/2022$83.00 → $65.00Buy
    Needham
    12/22/2021$75.00 → $68.00Buy
    BTIG
    12/21/2021$78.00 → $75.00Buy
    Truist Securities
    8/6/2021$70.00 → $77.00Market Outperform
    JMP Securities
    More analyst ratings

    $KIDS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Canaccord Genuity initiated coverage on OrthoPediatrics with a new price target

    Canaccord Genuity initiated coverage of OrthoPediatrics with a rating of Buy and set a new price target of $24.00

    12/10/25 8:29:38 AM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    Lake Street initiated coverage on OrthoPediatrics with a new price target

    Lake Street initiated coverage of OrthoPediatrics with a rating of Buy and set a new price target of $37.00

    4/7/25 8:25:17 AM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    OrthoPediatrics downgraded by Truist with a new price target

    Truist downgraded OrthoPediatrics from Buy to Hold and set a new price target of $31.00 from $39.00 previously

    1/25/24 7:05:43 AM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    $KIDS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    OrthoPediatrics Corp. Expands Specialty Bracing Portfolio with Two New Product Launches

    WARSAW, Ind., Nov. 13, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the expansion of its OrthoPediatrics Specialty Bracing ("OPSB") portfolio with two new products launches, the PediHip™ Rigid Brace and PediHip™ Modular Abduction Systems. The company now has 31 systems within its OPSB division. Developed in collaboration with globally recognized pediatric hip experts, the PediHip™ Rigid Brace and PediHip™ Modular Abduction System are intended for the treatment of Developmental Dysplasia of the Hip (DDH) and post-operative stabilization in ped

    11/13/25 7:00:00 AM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    OrthoPediatrics to Participate in Upcoming Conferences

    WARSAW, Ind., Nov. 04, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, a company focused exclusively on advancing the field of pediatric orthopedics, today announced that it will participate in three upcoming investor conferences. Event: Stifel 2025 Healthcare Conference Format: Fireside Chat Date: Thursday, November 13, 2025Time: 1:20 pm ET Event: Jeffries Global Healthcare Conference in LondonFormat: Presentation Date: Tuesday, November 18, 2025Time: 12:00 pm ET Event: Piper 37th Annual Healthcare Conference Format: Fireside Chat Date: Thursday, December 4,

    11/4/25 4:05:00 PM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    OrthoPediatrics Corp. Reports Third Quarter 2025 Financial Results

    WARSAW, Ind., Oct. 28, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the third quarter ended September 30, 2025. Third Quarter 2025 and Recent Business Highlights       Helped over 37,000 children in the third quarter of 2025 and approximately 1.3 million children to dateGenerated new record high total revenue of $61.2 million for the third quarter of 2025, up 12% from $54.6 million in third quarter 2024; domestic revenue increased 14% and international revenue increased 6% in the quarterGenerated total revenue exclu

    10/28/25 4:05:00 PM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    $KIDS
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by OrthoPediatrics Corp.

    SCHEDULE 13G/A - ORTHOPEDIATRICS CORP (0001425450) (Subject)

    11/12/25 1:52:08 PM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    SEC Form SCHEDULE 13G filed by OrthoPediatrics Corp.

    SCHEDULE 13G - ORTHOPEDIATRICS CORP (0001425450) (Subject)

    11/4/25 4:22:52 PM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    SEC Form 10-Q filed by OrthoPediatrics Corp.

    10-Q - ORTHOPEDIATRICS CORP (0001425450) (Filer)

    10/29/25 1:03:56 PM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    $KIDS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    COO and CFO Hite Fred bought $98,525 worth of shares (5,076 units at $19.41), increasing direct ownership by 2% to 213,065 units (SEC Form 4)

    4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)

    8/25/25 10:24:55 AM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    $KIDS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Fischer Kelly Laine was granted 4,345 shares (SEC Form 4)

    4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)

    11/12/25 4:38:27 PM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    New insider Fischer Kelly Laine claimed no ownership of stock in the company (SEC Form 3)

    3 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)

    11/12/25 11:30:46 AM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    COO and CFO Hite Fred bought $98,525 worth of shares (5,076 units at $19.41), increasing direct ownership by 2% to 213,065 units (SEC Form 4)

    4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)

    8/25/25 10:24:55 AM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    $KIDS
    Financials

    Live finance-specific insights

    View All

    OrthoPediatrics Corp. Reports Third Quarter 2025 Financial Results

    WARSAW, Ind., Oct. 28, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the third quarter ended September 30, 2025. Third Quarter 2025 and Recent Business Highlights       Helped over 37,000 children in the third quarter of 2025 and approximately 1.3 million children to dateGenerated new record high total revenue of $61.2 million for the third quarter of 2025, up 12% from $54.6 million in third quarter 2024; domestic revenue increased 14% and international revenue increased 6% in the quarterGenerated total revenue exclu

    10/28/25 4:05:00 PM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    OrthoPediatrics Corp. to Report Third Quarter Financial Results on October 28, 2025

    WARSAW, Ind., Oct. 15, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its third quarter 2025 financial results on October 28, 2025 after the market closes. OrthoPediatrics will host a conference call on Tuesday, October 28, 2025 at 4:30 p.m. ET to discuss the results. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.orthopediatrics.com, on the Investors page in the Events & Presentations section. The webcast will be available

    10/15/25 4:05:00 PM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    OrthoPediatrics Corp. Announces Preliminary Third Quarter 2025 Revenue and Revised 2025 Guidance

    WARSAW, Ind., Oct. 09, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced preliminary unaudited financial highlights for the third quarter ended September 30, 2025, and revised 2025 financial guidance. Preliminary Third Quarter 2025 Results Helped over 37,100 children in the third quarter 2025, the Company has now helped approximately 1.3 million children since inceptionGenerated preliminary unaudited third quarter 2025 net revenue of approximately $61.2 million, representing growth of 12% compared to $54.6 million in the third quarter of 2024. P

    10/9/25 4:05:00 PM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    $KIDS
    Leadership Updates

    Live Leadership Updates

    View All

    OrthoPediatrics Corp. Announces the Appointment of Kelly Fischer to its Board of Directors

    WARSAW, Ind., Aug. 25, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the appointment of Kelly Fischer to its Board of Directors effective as of August 8, 2025. The appointment was made concurrent with the announcement of the retirement of Terry Schlotterback from the OrthoPediatrics Board of Directors, effective as of August 8, 2025. "We're excited to welcome Kelly Fischer to the OrthoPediatrics Board of Directors. Her proven expertise in financial leadership at Cook Medical will be a significant asset as we execute our strategy and expand our

    8/25/25 4:05:00 PM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    OrthoPediatrics Corp. Joins Crossroads Pediatric Device Consortium to Advance Pediatric Medical Device Innovation

    WARSAW, Ind., March 17, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today its partnership with the Crossroads Pediatric Device Consortium (CPDC). This collaboration aligns with the Company's cause of improving the lives of children by supporting the development and commercialization of innovative pediatric medical devices.​ The Crossroads Pediatric Device Consortium is a multi-institutional initiative focused on accelerating the development, approval, and availability of medical devices designed specifically for pediatric patients. Founding member

    3/17/25 4:05:00 PM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    OrthoPediatrics Joins Alliance for Pediatric Device Innovation

    WARSAW, Ind., Oct. 12, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS) a company focused exclusively on advancing the field of pediatric orthopedics, has announced a strategic partnership with Children's National Hospital in Washington, DC under the "Alliance for Pediatric Device Innovation" (APDI), to advice the development and commercialization of medical devices designed for children. Along with Children's National, APDI consortium members include Johns Hopkins University, CIMIT at Mass General Brigham, Tufts Medical Center and Medstar Health Research Institute. The Company will serve as APDI's strategic advisor and role model for devic

    10/12/23 8:05:00 AM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    $KIDS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by OrthoPediatrics Corp.

    SC 13G/A - ORTHOPEDIATRICS CORP (0001425450) (Subject)

    11/14/24 1:34:08 PM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by OrthoPediatrics Corp. (Amendment)

    SC 13G/A - ORTHOPEDIATRICS CORP (0001425450) (Subject)

    5/8/24 2:22:57 PM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by OrthoPediatrics Corp. (Amendment)

    SC 13G/A - ORTHOPEDIATRICS CORP (0001425450) (Subject)

    2/14/24 3:33:43 PM ET
    $KIDS
    Medical/Dental Instruments
    Health Care